BiomX Inc. (NYSE:PHGE) Announces Reverse Stock Split

Core Viewpoint - BiomX Inc. is preparing for a reverse stock split to enhance its stock price and marketability, consolidating every 19 shares into 1 new share, effective November 25, 2025 [1][2]. Company Overview - BiomX Inc. is a clinical-stage company focused on developing phage therapies that target specific pathogenic bacteria [1]. - The company's current stock price is $0.29, reflecting an 8.31% decrease from the previous trading session [2]. Stock Performance - Over the past year, BiomX's stock has experienced significant volatility, with a high of $1.161 and a low of $0.29 [3]. - The company's market capitalization is approximately $7.7 million, indicating its current valuation in the market [3]. - The trading volume on the AMEX exchange is 310,088 shares, suggesting active investor interest [3]. Reverse Stock Split Details - The Board of Directors approved the one-for-nineteen reverse stock split ratio on November 13, 2025 [2]. - Following the reverse stock split, the stock will continue to trade under the symbol "PHGE" on the NYSE American, with a new CUSIP number of 09090D 509 [2].